Shaun Crowe

Please note this page was last updated in 2019. Visit Shaun’s LinkedIn profile for more information.

Shaun is an outcomes focused transformational change leader with over 13 years experience of delivering innovative large-scale change programmes in collaboration with NHS, local authority, other statutory, voluntary sector and industry partners. He is the Head of Clinical Network Development at NHS England & Improvement (London).

Shaun has led for London on improving access to psychological therapies (IAPT), health and care integration, mental health & social inclusion and currently diabetes transformation. Shaun was also the Chief Architect of the Healthy London Partnership’s Proactive Care programme and influenced the region’s strategies on social prescribing, personalisation and new models of digitally enhanced care.

Digital Pioneer Fellowship project: Improve clinician, patient and analyst access to integrated data-sets for Diabetes

Problem: Diabetes is a leading cause of mortality and morbidity, with costs associated with the treatment of diabetes complications estimated to cost 11% of the total NHS budget in England.

Solution: To improve clinician, patient and analyst access to integrated data-sets, providing a real-time information service based on point of care entered data. This will be achieved by:

• The wider availability of an integrated patient-facing record to support people to improve self-management, including the provision of proactive and personalised information to help reduce complications.
• Providing an integrated clinical record for healthcare professionals to support greater efficiency and improve informed decision making – using dashboards to enhance data visualisation and clarity.
• The development of agreed pan-London commissioning standards for both the Type1 and Type2  diabetes populations to monitor improvements in care, activity and finances.
• The development of predictive modelling, deep data insights and identifying patients most likely to benefit from more intensive support.

Scale: All of London’s five STPs. This involves an estimated London diabetes population of 697,963 and non-diabetic hyperglycaemia prevalence of 749,777.

Desired impact: The new capability aims to improve detection and prevention of diabetes and achieve improved outcomes and experience of care for both Type1 and Type2 diabetes populations. This is linked with reducing risk factors and avoiding complications such as preventable blindness, leg amputations and renal dialysis. The project also aims to optimise the value of data, enhance productivity, reduce health and social care costs.

Progress to date: The diabetes work-stream of the LHCRE programme is in the demonstrator phase. A diabetes clinical and patient leadership group has formed, held a series of workshops, and has agreed common data and a dataset; KPIs/metrics; and user-interfaces for dashboards and clinical and patient facing records that now require further consultation and user-testing with a wider community.